🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhuoya Wan

University of Pittsburgh

ORCID: 0000-0001-6747-7100

Also affiliated with AbbVie (United States), Genomics (United Kingdom)

EngineeringMaterials ScienceBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer”.

Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer

Acta Biomaterialia(2020)10.1016/j.actbio.2020.01.019
N/A
0DataRank · unranked
48 citations

Jieni Xu, Jingjing Sun, Haozhe Huang, Ziqian Zhang, Weina Ma +5 more

Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer

Biomaterials(2020)10.1016/j.biomaterials.2020.120629
N/A
0DataRank · unranked
44 citations

Zhuoya Wan, Jieni Xu, Zhangyi Luo, Pengfei Ren, Bei Zhang +4 more

Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages

Acta Pharmaceutica Sinica B(2021)10.1016/j.apsb.2021.09.024
N/A
0DataRank · unranked
79 citations

Zhuoya Wan, Apurva Pardeshi, Jiang Li, Haozhe Huang, Zhangyi Luo +8 more

A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death

Biomaterials(2021)10.1016/j.biomaterials.2021.120708
N/A
0DataRank · unranked
22 citations

Yixian Huang, Yuang Chen, Zhangyi Luo, Ziqian Zhang, Runzi Sun +7 more

Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid

Biochemical Pharmacology(2021)10.1016/j.bcp.2021.114453
N/A
0DataRank · unranked
18 citations

Jingjing Sun, Yixian Huang, Yichao Chen, Jiang Li, Lei Liang +6 more

Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination

Molecular Therapy — Nucleic Acids(2021)10.1016/j.omtn.2021.09.006
N/A
0DataRank · unranked
14 citations

Yixian Huang, Haozhe Huang, Zhangyi Luo, Ziqian Zhang, Runzi Sun +5 more

Metabotropic Receptors 4 and the Immune Responses

IntechOpen eBooks(2021)10.5772/intechopen.100272
N/A
0DataRank · unranked
0 citations

Song Li, Zhuoya Wan

Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier

Materials Today(2022)10.1016/j.mattod.2022.11.008
N/A
0DataRank · unranked
60 citations

Haozhe Huang, Raymond E. West, Min Zhang, Bei Zhang, Xinran Cai +11 more

In Situ Formation of Fibronectin‐Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy

Advanced Science(2024)10.1002/advs.202307940
N/A
0DataRank · unranked
15 citations

Zhuoya Wan, Pengfei Ren, Bei Zhang, Yixian Huang, Raymond E. West +8 more